Related Experiment Video
Updated: Feb 9, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Arterial hypertension. Does the J curve exist? And then?
1Italian Association for Cardiovascular Prevention and Rehabilitation, Department of Internal Medicine, San Giovanni-Addolorata Hospital. mureddu.gianfra@gmail.com.
The J-shaped curve, suggesting harm from very low blood pressure, is not observed in the general population. It appears primarily in elderly patients with comorbidities and extensive atherosclerosis, where impaired blood flow regulation can cause harm.
Area of Science:
- Cardiovascular Medicine
- Geriatrics
- Epidemiology
Background:
- The 'lower the better' concept for blood pressure (BP) management is challenged by the J-shaped curve hypothesis, suggesting risks with very low BP.
- Previous studies indicated a continuous relationship between rising BP and adverse outcomes, even at lower levels.
Purpose of the Study:
- To investigate the existence and specific patient populations associated with the J-shaped relationship between blood pressure and adverse outcomes.
- To clarify the BP-outcome relationship across different age groups and in the presence of comorbidities.
Main Methods:
- Analysis of large cohort data (61 cohorts, 1 million individuals) and contemporary studies (CALIBER, ELSA).
- Review of randomized controlled trials (SPRINT, HYVET, INVEST) focusing on specific patient subgroups.
- Examination of physiological mechanisms like impaired coronary blood flow autoregulation and diastolic dysfunction.
Main Results:
- Contemporary data show a continuous rise in outcomes with increasing BP, without a J-shaped association in the general population, even in octogenarians.
- The J-shaped curve was primarily observed in randomized trials involving patients with significant atherosclerotic burden or multiple comorbidities.
- Physiological factors such as impaired coronary blood flow autoregulation and diastolic dysfunction contribute to adverse outcomes in specific elderly populations.
Conclusions:
- The J-shaped relationship between blood pressure and adverse outcomes is not a universal phenomenon but is confined to specific patient groups.
- Elderly individuals with extensive atherosclerosis, comorbidities, and conditions like heart failure with preserved ejection fraction are at risk for J-curve effects.
- Understanding these specific risk factors is crucial for safe and effective blood pressure management in vulnerable populations.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Acid-Base Titration Curves
For a titration carried out for 25.00 mL of...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

